BiotechTube

DGD

Phase 3Completed
0 views this week 0 watching💤 Quiet
Interest: 30/100
30
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Burn

Conditions

Burn

Trial Timeline

Dec 1, 2005 → Feb 1, 2010

NCT ID
NCT00324311

About DGD

DGD is a phase 3 stage product being developed by MediWound for Burn. The current trial status is completed. This product is registered under clinical trial identifier NCT00324311. Target conditions include Burn.

What happened to similar drugs?

10 of 20 similar drugs in Burn were approved

Approved (10) Terminated (2) Active (10)
✅CefiderocolShionogiApproved
🔄rabeprazole sodiumEisaiPhase 3
🔄rabeprazole sodium + placeboEisaiPhase 3
✅esomeprazole 40 mgAstraZenecaApproved
✅Esomeprazole magnesium (Nexium)AstraZenecaApproved
🔄EsomeprazoleAstraZenecaPhase 3
🔄EsomeprazoleAstraZenecaPhase 3

Hype Score Breakdown

Clinical
17
Activity
8
Company
5
Novelty
0
Community
0

Clinical Trials (2)

NCT IDPhaseStatus
NCT00898521Phase 2Completed
NCT00324311Phase 3Completed

Competing Products

20 competing products in Burn

See all competitors
ProductCompanyStageHype Score
CefiderocolShionogiApproved
50
rabeprazole sodiumEisaiPhase 3
40
rabeprazole sodium + placeboEisaiPhase 3
40
Rabeprazole sodiumEisaiPre-clinical
26
famotidine (+) calcium carbonate (+) magnesium hydroxide tablet + Comparator: famotidine (+) calcium carbonate (+) magnesium hydroxide EZ Chew tablet without water + Comparator: famotidine (+) calcium carbonate (+) magnesium hydroxide EZ Chew tablet with waterJohnson & JohnsonPhase 1
29
R-Pdf/Gbb 0.01% gelJohnson & JohnsonPhase 2
31
esomeprazole 40 mgAstraZenecaApproved
43
Esomeprazole magnesium (Nexium)AstraZenecaApproved
43
EsomeprazoleAstraZenecaPhase 3
40
EsomeprazoleAstraZenecaPhase 3
40
Esomeprazole + Lansoprazole + PantoprazoleAstraZenecaApproved
43
Esomeprazole Magnesium + LansoprazoleAstraZenecaApproved
43
Ceftolozane/tazobactamMerckApproved
35
Famotidine FCT + Famotidine CTMerckPhase 1
29
LanzoprazoleNovartisPhase 3
40
Lansoprazole + Lansoprazole + placeboNovartisPhase 3
40
LansoprazoleNovartisPhase 3
40
Diclofenac sodium 1mg/gNovartisPhase 3
40
BVS857NovartisPhase 2
27
TegaserodNovartisPhase 3
40